根据一项新的临床试验，一种强效的抗胆固醇药物可以将合并高水平炎症的的心脏病发作和卒中事件减半。

A powerful cholesterol drug cuts the incidence of heart attack and stroke in half when given to people with high levels of inflammation, according to a new clinical trial.

youdao

2006年希腊一项新的更大国际间临床试验研究回报了结果，这项研究称为强化降胆固醇预防卒中研究(SPARCL)。

The new Greek study echoes findings from an even bigger international trial, reported in 2006, called Stroke Prevention by Aggressive Reduction in Cholesterol Levels (SPARCL).

youdao

调查结果基于一项新的数据分析，而后者来自于一个积极降低胆固醇水平(SPARCL)而以此预防卒中的试验。

The findings are based on a new analysis of data from the Stroke Prevention by Aggressive Reduction in Cholesterol Levels (SPARCL) trial.

youdao